Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.43 |
| ▸ | KDM1A | O60341 | 4/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6902549 | 0.77 | SIGMAR1 (0.43) | SIGMAR1KDM1AMAOBGRIN1GRIN2A | |
| SCHEMBL7609559 | 0.76 | KDM1A (0.39) | SIGMAR1KDM1AMAOBALDH1A1TP53 | |
| SCHEMBL14489209 | 0.75 | KDM1A (0.42) | SIGMAR1KDM1AMAOBALDH1A1TP53 | |
| SCHEMBL8849610 | 0.73 | SIGMAR1 (0.50) | SIGMAR1KDM1AMAOBALDH1A1TP53 | |
| SCHEMBL1515317 | 0.70 | GRIN1 (0.46) | GRIN1GRIN2AGRIN2BSLC6A2TDP1 | |
| Methyl Alcohol SCHEMBL14815696 | 0.69 | KDM1A (0.46) | SIGMAR1KDM1AMAOBALDH1A1TP53 | |
| SCHEMBL8865262 | 0.68 | KDM1A (0.47) | SIGMAR1KDM1AMEN1KMT2A | |
| SCHEMBL13330631 | 0.68 | OPRL1 (0.37) | SIGMAR1KDM1AGRIN1GRIN2BMEN1 | |
| SCHEMBL7457135 | 0.68 | KDM1A (0.42) | SIGMAR1KDM1AMAOBALDH1A1TP53 | |
| SCHEMBL28617264 | 0.68 | KDM1A (0.42) | SIGMAR1KDM1AMAOBALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100121065-A1 | Phosphors with High Luminous Efficiency and Display Device Containing Them | GRACEL DISPLAY INC. (KR) | 2010-05-13 | — | — | US | disclosed |
| US-20100121065-A1 | Phosphors with High Luminous Efficiency and Display Device Containing Them | GRACEL DISPLAY INC. (KR) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100121065-A1 | Phosphors with High Luminous Efficiency and Display Device Containing Them | PPIP5K2, ACP1, INPP5B | SIGMAR1 2511/4885KDM1A 4615/4885MAOB 2562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.